buprenorphine/naloxone sublingual film / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

7 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
buprenorphine/naloxone sublingual film / Generic mfg.
NCT03291847: Maternal Buprenorphine-naloxone Treatment and the Infant

Completed
2
42
US
fetal monitoring, maternal physiology monitoring, Buprenorphine Naloxone, Suboxone
Johns Hopkins University, National Institute on Drug Abuse (NIDA)
Maternal Opioid Use Disorder, Opioid Exposed Infant
12/22
12/23
NCT04234191: Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Recruiting
2
50
Canada
Buprenorphine/naloxone, Suboxone, Hydromorphone, Dihydromorphinone, Dilaudid
University of British Columbia, Vancouver Coastal Health
Opioid Use Disorder
01/25
01/25
NCT06406400: Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).

Recruiting
2
100
US
AZD4041, Itraconazole, Sporanox®, Buprenorphine, Belbuca®, Buprenorphine / Naloxone, Suboxone®, Hydromorphone, Dilaudid®, Placebo
AstraZeneca, Parexel
Opioid Use Disorder
05/26
05/26
AMOHI-1, NCT04480554: Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

Recruiting
2
225
US, RoW
Methadone, Buprenorphine/naloxone, Suboxone, XR-Naltrexone, Vivitrol
University of Pennsylvania, National Institute of Drug Abuse, The Wistar Institute, Institute of Applied Medicine and Epidemiology (IMEA), Ho Chi Minh City CDC
Opioid-use Disorder, HIV-1-infection, Immune Activation, Inflammation, Methadone, Buprenorphine, Naltrexone, Antiretroviral Treatment
06/24
06/24
BOPAT, NCT04677114: Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections

Recruiting
2
90
US
Buprenorphine and Outpatient Parenteral Antibiotic Therapy, Suboxone or Sublocade, Buprenorphine and standard of care antibiotic treatment
Laura Fanucchi, National Institute on Drug Abuse (NIDA)
Drug Use, Opioid-use Disorder
08/24
12/24
PEDsTREATOUD, NCT04737603: Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder

Not yet recruiting
2
24
NA
ED-Initiated treatment with buprenorphine / naloxone, Suboxone
University of California, Davis, Yale University, University of Utah
Opioid-use Disorder
07/25
07/25
NCT04464980: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Recruiting
2
2190
US
SL-BUP, sublingual buprenorphine, Suboxone, XR-BUP, extended-release buprenorphine, CAM2038, Brixadi, XR-NTX, extended-release naltrexone, Vivitrol, MM, MMR, MMD
NYU Langone Health, New York State Psychiatric Institute, Columbia University, Harvard Medical School (HMS and HSDM), Mclean Hospital, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Opioid Use Disorder (OUD)
07/26
12/26

Download Options